Novavax May Get Approval In 2 Months, Likely To Cost More Than Covishield | Left, Right & Centre

The Covovax shot developed by American vaccine-maker Novavax may be cleared for use in India between July and September, which would make it the fifth vaccine in the country. The vaccine would cost a "low single dollar" price per dose but is likely to be costlier than Covishield, the company's CEO said today in an exclusive interview. Stanley Erck, the president and CEO of Novavax, also said that while Covovax is known to work on Covid variants, the data of its effectiveness against the Delta variant is not known yet.

About Us: NDTV brings you unbiased and comprehensive coverage of news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe to our channels:
NDTV: https://www.youtube.com/user/ndtv?sub_confirmation=1
NDTV India (Hindi News): https://www.youtube.com/user/ndtvindia?sub_confirmation=1

Follow us on Social Media:
Like us on Facebook: https://www.facebook.com/ndtv/
Follow us on Twitter: https://twitter.com/ndtv/
Follow us on Instagram: https://www.instagram.com/ndtv/
Join NDTV on Telegram Messenger: https://t.me/NDTVbot/?start=hi

Follow us on Google News for Breaking and Latest News Updates:
NDTV: https://bit.ly/3e5ngbP
NDTV India (Hindi News): https://bit.ly/3mNVwMY

Download NDTV Mobile Apps:
http://www.ndtv.com/page/apps

Watch More Videos:
http://www.ndtv.com/video?yt

#LeftRightCentre

Видео Novavax May Get Approval In 2 Months, Likely To Cost More Than Covishield | Left, Right & Centre канала NDTV